Piper Sandler cuts Axsome Therapeutics target price to $235 from $238
AXSM•Piper Sandler cut its target price for Axsome Therapeutics to $235 from $238.
Related News
Piper Sandler: BofA Global Research cuts price objective to $69 from $75
PIPR•
Tempus AI upgraded to hold from underperform; price target raised to $70 from $35
TEM•
Asian stocks retreat ahead of US midterms, oil steadies
SPY•
Fresenius Medical Care Q3 2026 net income drops 42% year over year to EUR 160 million
FMS•
Jazz Pharmaceuticals target price raised to $305 from $296 by RBC
JAZZ•